Chris Grashoff
About Chris Grashoff
Chris Grashoff serves as the Chief Growth Officer at Option Care Health, a position he has held since 2023. With over 20 years of experience in global healthcare, he has held various leadership roles, including significant positions at Baxter International and Naven Health.
Work at Option Care Health
Chris Grashoff currently serves as the Chief Growth Officer at Option Care Health, a position he has held since 2023. Prior to this role, he worked as the Senior Vice President of Chronic Sales & Marketing for a brief period in early 2023. His responsibilities include overseeing growth strategies and initiatives aimed at enhancing the company's market position. Grashoff has also played a significant role in the integration of Option Care Health and BioScrip following their merger in 2019.
Education and Expertise
Chris Grashoff earned his MBA from Harvard Business School, where he studied from 2005 to 2007. He also holds a Bachelor of Arts degree in Economics from DePauw University, which he completed from 1997 to 2001. With over 20 years of experience in global healthcare, Grashoff has developed expertise in leadership, general management, and patient-centric healthcare solutions across various sectors, including provider services, medical devices, and pharmaceuticals.
Background
Chris Grashoff began his career at Eli Lilly and Company, where he held various roles, including Financial Analyst and Country Analyst for Latin America & Canada. He later transitioned to Baxter International Inc., where he spent nearly 12 years in multiple leadership positions, including Vice President of Renal Care Services and Global Franchise Head for In-Center Hemodialysis. His international experience includes living in Sweden during his tenure at Baxter.
Achievements
During his career, Chris Grashoff has led significant initiatives, including the strategy and execution of over 160 Ambulatory Infusion Suite locations at Naven Health. He has a proven track record in advancing healthcare solutions and has been instrumental in leading marketing organizations within the renal care sector at Baxter International. His leadership during the merger of Option Care Health and BioScrip highlights his capabilities in managing complex business integrations.